Publications 2/2

top of page

N1C Annual Meeting
Our Story
Resource Navigator
Who We Are
- Collaborating Organizations
News + Seminars
- Podcast
- Data Sharing
Donated Resource Center
Team
More

Use tab to navigate through the menu items.

Latest News
Seminar Series
Publications
Workshops & Presentations
Articles & Podcasts
Newsletter
Regulatory Guidances
Illustrated Examples
Temp Category
Announcements

Search

Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide

OTS Rare Disease N-of-1+ Briefing Document, Jan 2020

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease

Drug Regulation in the Era of Individualized Therapies

Join Our Community List

First Name

Credentials (MD, PhD, etc)

Affiliation(s)

Relationship * Required

Clinician (physician

Researcher / investigator

Patient

Other

Last Name

Email

Country

Area(s) of Interest * Required

General interest

Patient identification and selection

Trial implementation

Clinical outcome measures

Toxicology and safety

Data sharing

Ethics and equity

Other

What brought you to the N=1 Collaborative? What are you hoping to gain, contribute, learn, or participate in?

Thanks for submitting!

N=1 Collaborative

Contact Us

info@n1collaborative.org

501c3 Nonprofit Organization

EIN: 88-2591503

©2024 by N=1 Collaborative

Crafted By: Finfrock Marketing

bottom of page